News Krebs Biochemicals & Industries Limited NSE India S.E.

Equities

KREBSBIO

INE268B01013

Market Closed - NSE India S.E. Other stock markets 07:43:55 2024-06-28 EDT			5-day change	1st Jan Change
70.95 ^INR	-0.49%		-2.78%	-9.44%

05-21	Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer	CI
05-21	Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer	05-21	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-21	CI
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer	04-15	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer	01-17	CI
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant	12-18	MT
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer	23-10-20	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-09	CI
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director	23-08-09	CI
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023	23-08-09	CI
Krebs Biochemicals Trims Net Loss in Fiscal Q4	23-05-24	MT
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-24	CI
Krebs Biochemicals Names New CFO	23-02-03	MT
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer	23-02-03	CI
Krebs Biochemicals & Industries Limited Approves CFO Changes	23-02-03	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-10	CI
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt	22-09-05	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-01	CI
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022	22-08-01	CI
Krebs Biochemicals & Industries : Financial Result Updates	22-05-23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Krebs Biochemicals & Industries Limited NSE India S.E.

Equities

KREBSBIO

INE268B01013

Summary

Filters